Home
About
Overview
Sharing Data
ORCID
Help
History (45)
Pancreatic adenocarcinoma.
Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine.
Cholangiocarcinoma.
Anthropometric model of total body volume for males of different sizes.
Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice.
See All 45 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice.
Hesketh PJ. Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice. Oncologist. 1999; 4(3):191-6.
View in:
PubMed
subject areas
Antiemetics
Antineoplastic Agents
Humans
Neoplasms
Patient Selection
Practice Guidelines as Topic
Risk Factors
Vomiting
authors with profiles
Paul Joseph Hesketh MD